Praxis Precision Medicines
PRAX
PRAX
80 hedge funds and large institutions have $751M invested in Praxis Precision Medicines in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.04% less ownership
Funds ownership: 6.33% → 6.29% (-0.04%)
37% less capital invested
Capital invested by funds: $1.19B → $751M (-$437M)
53% less call options, than puts
Call options by funds: $111K | Put options by funds: $236K
Holders
80
Holding in Top 10
2
Calls
$111K
Puts
$236K
Top Buyers
| 1 | +$35M | |
| 2 | +$28M | |
| 3 | +$11.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.65M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$8.32M |
Top Sellers
| 1 | -$49.4M | |
| 2 | -$28M | |
| 3 | -$6.93M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.05M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$3.26M |